Search Results - "Sillevis Smitt, Peter A. E."

Refine Results
  1. 1

    Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigens by Weenink, Bas, Draaisma, Kaspar, Ooi, Han Z., Kros, Johan M., Sillevis Smitt, Peter A. E., Debets, Reno, French, Pim J.

    Published in Scientific reports (10-10-2019)
    “…In multiple tumor types, prediction of response to immune therapies relates to the presence, distribution and activation state of tumor infiltrating…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis by Stoop, Marcel P, Singh, Vaibhav, Dekker, Lennard J, Titulaer, Mark K, Stingl, Christoph, Burgers, Peter C, Sillevis Smitt, Peter A E, Hintzen, Rogier Q, Luider, Theo M

    Published in PloS one (27-08-2010)
    “…Based on clinical representation of disease symptoms multiple sclerosis (MScl) patients can be divided into two major subtypes; relapsing remitting (RR) MScl…”
    Get full text
    Journal Article
  4. 4

    Serum Levels of Pregnancy Zone Protein are Elevated in Presymptomatic Alzheimer’s Disease by IJsselstijn, Linda, Dekker, Lennard J. M, Stingl, Christoph, van der Weiden, Marcel M, Hofman, Albert, Kros, Johan M, Koudstaal, Peter J, Sillevis Smitt, Peter A. E, Ikram, M. Arfan, Breteler, Monique M. B, Luider, Theo M

    Published in Journal of proteome research (04-11-2011)
    “…We have sought for disease-related proteins that could predict the onset of Alzheimer’s disease (AD) in a study population derived from the Rotterdam Scan…”
    Get full text
    Journal Article
  5. 5

    Anti‐LGI1 encephalitis is strongly associated with HLA‐DR7 and HLA‐DRB4 by van Sonderen, Agnes, Roelen, Dave L., Stoop, Johannes A., Verdijk, Robert M., Haasnoot, Geert W., Thijs, Roland D., Wirtz, Paul W., Schreurs, Marco W. J., Claas, Frans H. J., Sillevis Smitt, Peter A. E., Titulaer, Maarten J.

    Published in Annals of neurology (01-02-2017)
    “…Leucine‐rich glioma‐inactivated1 (LGI1) encephalitis is an antibody‐associated inflammation of the limbic area. An autoimmune etiology is suspected but not yet…”
    Get full text
    Journal Article
  6. 6

    Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide by Taal, Walter, Brandsma, Dieta, de Bruin, Hein G., Bromberg, Jacoline E., Swaak‐Kragten, Annemarie T., Sillevis Smitt, Peter A. E., van Es, Corine A., van den Bent, Martin J.

    Published in Cancer (15-07-2008)
    “…BACKGROUND. Radiotherapy (RT) plus concomitant and adjuvant temozolomide (TMZ) is now the standard of care for patients with newly diagnosed glioblastoma. The…”
    Get full text
    Journal Article
  7. 7

    Addition of serum-containing medium to cerebrospinal fluid prevents cellular loss over time by de Graaf, Marieke T., van den Broek, Patricia D. M., Kraan, Jaco, Luitwieler, Ronald L., van den Bent, Martin J., Boonstra, Joke G., Schmitz, Paul I. M., Gratama, Jan W., Sillevis Smitt, Peter A. E.

    Published in Journal of neurology (01-08-2011)
    “…Immediately after sampling, leukocyte counts in native cerebrospinal fluid (CSF) start to decrease rapidly. As the time lapse between CSF collection to…”
    Get full text
    Journal Article
  8. 8

    Increased levels of circulating endothelial progenitor cells and circulating endothelial nitric oxide synthase in patients with gliomas by Zheng, Ping-Pin, Hop, Wim C., Luider, Theodorus M., Sillevis Smitt, Peter A. E., Kros, Johan M.

    Published in Annals of neurology (01-07-2007)
    “…Objective Gliomas are among the highest vascularized tumors. We hypothesized that patients with gliomas have increased levels of circulating endothelial…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Metabolic changes related to the IDH1 mutation in gliomas preserve TCA‐cycle activity: An investigation at the protein level by Dekker, Lennard J. M., Wu, Suying, Jurriëns, Cherise, Mustafa, Dana A. N., Grevers, Frederieke, Burgers, Peter C., Sillevis Smitt, Peter A. E., Kros, Johan M., Luider, Theo M.

    Published in The FASEB journal (01-03-2020)
    “…The discovery of the IDH1 R132H (IDH1 mut) mutation in low‐grade glioma and the associated change in function of the IDH1 enzyme has increased the interest in…”
    Get full text
    Journal Article
  11. 11

    Novel Antibody-Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma by Zeneyedpour, Lona, Stingl, Christoph, Kros, Johan M, Sillevis Smitt, Peter A E, Luider, Theo M

    “…We investigated the feasibility of detecting the presence of specific autoantibodies against potential tumor-associated peptide antigens by enriching these…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study by Taal, Walter, Segers-van Rijn, Joyce M. W., Kros, Johan M., van Heuvel, Irene, van der Rijt, Carin C. D., Bromberg, Jacoline E., Sillevis Smitt, Peter A. E., van den Bent, Martin J.

    Published in Journal of neuro-oncology (01-05-2012)
    “…Alternative temozolomide regimens have been proposed to overcome O 6 -methylguanine-DNA methyltransferase mediated resistance. We investigated the efficacy and…”
    Get full text
    Journal Article
  14. 14

    IDH1-mutated transgenic zebrafish lines: An in-vivo model for drug screening and functional analysis by Gao, Ya, de Wit, Maurice, Struys, Eduard A, van der Linde, Herma C Z, Salomons, Gajja S, Lamfers, Martine L M, Willemsen, Rob, Sillevis Smitt, Peter A E, French, Pim J

    Published in PloS one (28-06-2018)
    “…The gene encoding isocitrate dehydrogenase 1 (IDH1) is frequently mutated in several tumor types including gliomas. The most prevalent mutation in gliomas is a…”
    Get full text
    Journal Article
  15. 15

    Immune Repertoire after Immunization As Seen by Next-Generation Sequencing and Proteomics by VanDuijn, Martijn M, Dekker, Lennard J, van IJcken, Wilfred F J, Sillevis Smitt, Peter A E, Luider, Theo M

    Published in Frontiers in immunology (16-10-2017)
    “…The immune system produces a diverse repertoire of immunoglobulins in response to foreign antigens. During B-cell development, VDJ recombination and somatic…”
    Get full text
    Journal Article
  16. 16

    Serum Clusterin Levels Are Not Increased in Presymptomatic Alzheimer’s Disease by IJsselstijn, Linda, Dekker, Lennard J. M, Koudstaal, Peter J, Hofman, Albert, Sillevis Smitt, Peter A. E, Breteler, Monique M. B, Luider, Theo M

    Published in Journal of proteome research (01-04-2011)
    “…Increased plasma levels of clusterin have recently been found to be associated with severity and progression in Alzheimer’s disease (AD). We have investigated…”
    Get full text
    Journal Article
  17. 17

    Adherence to Analgesics in Oncology Outpatients: Focus on Taking Analgesics on Time by Oldenmenger, Wendy H., Sillevis Smitt, Peter A. E., Raaf, Pleun J., Rijt, Carin C. D.

    Published in Pain practice (01-06-2017)
    “…Background Inadequate adherence to prescribed analgesics may be one of the reasons why patients with cancer experience unrelieved pain. Adherence is directly…”
    Get full text
    Journal Article
  18. 18

    Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up by van Sonderen, Agnes, Thijs, Roland D, Coenders, Elias C, Jiskoot, Lize C, Sanchez, Esther, de Bruijn, Marienke A.A.M, van Coevorden-Hameete, Marleen H, Wirtz, Paul W, Schreurs, Marco W.J, Sillevis Smitt, Peter A.E, Titulaer, Maarten J

    Published in Neurology (04-10-2016)
    “…OBJECTIVE:This nationwide study gives a detailed description of the clinical features and long-term outcome of anti–leucine-rich glioma-inactivated 1 (LGI1)…”
    Get full text
    Journal Article
  19. 19
  20. 20

    The clinical spectrum of Caspr2 antibody–associated disease by van Sonderen, Agnes, Ariño, Helena, Petit-Pedrol, Mar, Leypoldt, Frank, Körtvélyessy, Peter, Wandinger, Klaus-Peter, Lancaster, Eric, Wirtz, Paul W, Schreurs, Marco W.J, Sillevis Smitt, Peter A.E, Graus, Francesc, Dalmau, Josep, Titulaer, Maarten J

    Published in Neurology (02-08-2016)
    “…OBJECTIVE:To report a large cohort of patients with antibodies against contactin-associated protein-like 2 (Caspr2) and provide the clinical spectrum of this…”
    Get full text
    Journal Article